Biosurgery Market, By Treatment Type (Hemostatic Agents, Bone-graft Substitutes, Surgical Sealants and Adhesives, Soft-tissue Attachments, Adhesion Barriers, and Staple Line Reinforcement), By Disease Type (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Biosurgery is promising adjunct to the whole spectrum of topical treatment methods, in particular for debridement. Biosurgery involves natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. Biosurgery products typically consist of natural, synthetic, or semi-synthetic materials that help seal surgical incisions and facilitate tissue repairs.
Market Dynamics:
Increase in prevalence of cardiovascular diseases, growing geriatric population, rise in adoption of advanced surgical tools and devices, increase in research & development, rising health awareness, and developing healthcare infrastructure are major factors expected to propel growth of the global biosurgery market during the forecast period.
For instance, according to the British Heart Foundation, United Kingdom Factsheet (August 2022), more than 7.6 million people are living in the United Kingdom in 2021 with some kind of heart and circulatory diseases. Moreover, in January 2020, Terumo launched its surgical sealant named AQUABRID in the EMEA market. AQUABRID is a new surgical sealant specially developed for aortic procedures. It is safe and effective in achieving hemostasis, even when blood coagulation is inhibited during cardiac surgery.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook